1qrk
From Proteopedia
| Line 1: | Line 1: | ||
| - | [[Image:1qrk.png|left|200px]] | ||
| - | |||
{{STRUCTURE_1qrk| PDB=1qrk | SCENE= }} | {{STRUCTURE_1qrk| PDB=1qrk | SCENE= }} | ||
| - | |||
===HUMAN FACTOR XIII WITH STRONTIUM BOUND IN THE ION SITE=== | ===HUMAN FACTOR XIII WITH STRONTIUM BOUND IN THE ION SITE=== | ||
| + | {{ABSTRACT_PUBMED_9988734}} | ||
| - | + | ==Disease== | |
| + | [[http://www.uniprot.org/uniprot/F13A_HUMAN F13A_HUMAN]] Defects in F13A1 are the cause of factor XIII subunit A deficiency (FA13AD) [MIM:[http://omim.org/entry/613225 613225]]. FA13AD is an autosomal recessive disorder characterized by a life-long bleeding tendency, impaired wound healing and spontaneous abortion in affected women.<ref>PMID:1353995</ref> | ||
| + | |||
| + | ==Function== | ||
| + | [[http://www.uniprot.org/uniprot/F13A_HUMAN F13A_HUMAN]] Factor XIII is activated by thrombin and calcium ion to a transglutaminase that catalyzes the formation of gamma-glutamyl-epsilon-lysine cross-links between fibrin chains, thus stabilizing the fibrin clot. Also cross-link alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. | ||
==About this Structure== | ==About this Structure== | ||
| Line 14: | Line 16: | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID:009988734</ref><references group="xtra"/> | + | <ref group="xtra">PMID:009988734</ref><references group="xtra"/><references/> |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Protein-glutamine gamma-glutamyltransferase]] | [[Category: Protein-glutamine gamma-glutamyltransferase]] | ||
Revision as of 02:42, 25 March 2013
Contents |
HUMAN FACTOR XIII WITH STRONTIUM BOUND IN THE ION SITE
Template:ABSTRACT PUBMED 9988734
Disease
[F13A_HUMAN] Defects in F13A1 are the cause of factor XIII subunit A deficiency (FA13AD) [MIM:613225]. FA13AD is an autosomal recessive disorder characterized by a life-long bleeding tendency, impaired wound healing and spontaneous abortion in affected women.[1]
Function
[F13A_HUMAN] Factor XIII is activated by thrombin and calcium ion to a transglutaminase that catalyzes the formation of gamma-glutamyl-epsilon-lysine cross-links between fibrin chains, thus stabilizing the fibrin clot. Also cross-link alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin.
About this Structure
1qrk is a 2 chain structure with sequence from Homo sapiens. This structure supersedes the now removed PDB entry 1bl2. Full crystallographic information is available from OCA.
See Also
Reference
- Fox BA, Yee VC, Pedersen LC, Le Trong I, Bishop PD, Stenkamp RE, Teller DC. Identification of the calcium binding site and a novel ytterbium site in blood coagulation factor XIII by x-ray crystallography. J Biol Chem. 1999 Feb 19;274(8):4917-23. PMID:9988734
